Aquestive Therapeutics AQST
NASDAQ AQST
$3.59 +0.07 (+1.99%)
As of: Nov 11, 2026 · 1:45 PM EST

Aquestive Therapeutics (AQST) Depreciation & Amortization (CF) (2017 - 2026)

Updated

Aquestive Therapeutics (AQST) posted Depreciation & Amortization (CF) of $156,000 for Q3 2026, up 12.2% from $139,000 a year earlier and up 14.7% from the prior quarter.

Analysis

Aquestive Therapeutics (AQST) Depreciation & Amortization (CF) (2017 - 2026) Analysis & Trends

For the trailing twelve months through Sep 30, 2026, Depreciation & Amortization (CF) at Aquestive Therapeutics was $535,000, down 5.3% year-over-year; for FY2025, it came in at $548,000, down 23.7% from FY2024.

  • Annual Depreciation & Amortization (CF) has declined for five consecutive years, with a five-year compound annual growth rate of -30.8% (FY2020 to FY2025).
  • In prior years, Aquestive Therapeutics' Depreciation & Amortization (CF) was $718,000 in FY2024 (-46.6%), $1.35 million in FY2023 (-43.7%), $2.39 million in FY2022 (-19.5%) and $2.96 million in FY2021 (-13.9%).
  • The Q3 2026 figure stands as the highest quarterly Depreciation & Amortization (CF) since Q3 2024.
  • On a year-over-year basis, Depreciation & Amortization (CF) increased in 1 of the last eight quarters, with an average decline of 20.8%.
  • The strongest year-over-year quarter for Depreciation & Amortization (CF) in the past five years was Q4 2023, with growth of 17.6%; the weakest was Q4 2024, with a decline of 68.5%.
  • According to Business Quant data, Depreciation & Amortization (CF) for the three prior quarters was $136,000 (Q2 2026), $113,000 (Q1 2026) and $130,000 (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 545.00 Mn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 2.12 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 192.00 Mn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 726.00 Mn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 1.61 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 1.12 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 132.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 1.58 Bn
10 Aquestive Therapeutics 442.42 Mn 21.68 Mn 3.95 Mn 156,000.00
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 156,000.00
Jun 30, 2026 136,000.00
Mar 31, 2026 113,000.00
Dec 31, 2025 130,000.00
Sep 30, 2025 139,000.00
Jun 30, 2025 140,000.00
Mar 31, 2025 139,000.00
Dec 31, 2024 147,000.00
Sep 30, 2024 159,000.00
Jun 30, 2024 205,000.00
Mar 31, 2024 207,000.00
Dec 31, 2023 467,000.00
Sep 30, 2023 264,000.00
Jun 30, 2023 289,000.00
Mar 31, 2023 325,000.00
Dec 31, 2022 397,000.00
Sep 30, 2022 596,000.00
Jun 30, 2022 667,000.00
Mar 31, 2022 727,000.00
Dec 31, 2021 731,000.00
API Access

Aquestive Therapeutics Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=AQST&period=max&api_key=YOUR_API_KEY